Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the agent causing the COVID-19 pandemic. SARS-CoV-2 B.1.1.7 (Alpha), a WHO variant of concern (VOC) first identified in the UK in late 2020, contains several mutations including P681H in the spike S1/S2 cleavage site, which is predicted to increase cleavage by furin, potentially impacting the viral cell entry. Here, we studied the role of the P681H mutation in B.1.1.7 cell entry. We performed assays using fluorogenic peptides mimicking the Wuhan-Hu-1 and B.1.1.7 S1/S2 sequence and observed no significant difference in furin cleavage. Functional assays using pseudoparticles harboring SARS-CoV-2 spikes and cell-to-cell fusion assays demonstrated no differences between Wuhan-Hu-1, B.1.1.7 or a P681H point mutant. Likewise, we observed no differences in viral growth between USA-WA1/2020 and a B.1.1.7 isolate in cell culture. Our findings suggest that while the B.1.1.7 P681H mutation may slightly increase S1/S2 cleavage this does not significantly impact viral entry or cell-cell spread.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043443 | PMC |
| http://dx.doi.org/10.1101/2021.04.06.438731 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Molecular Characterization and Genomic Surveillance of SARS-CoV-2 Lineages in Central India.
Viruses
October 2024
ICMR-National Institute of Research in Tribal Health, Jabalpur 482003, Madhya Pradesh, India.
Since the first reported case of COVID-19 in December 2019, several SARS-CoV-2 variants have evolved, and some of them have shown higher transmissibility, becoming the prevalent strains. Genomic epidemiological investigations into strains from different time points, including the early stages of the pandemic, are very crucial for understanding the evolution and transmission patterns. Using whole-genome sequences, our study describes the early landscape of SARS-CoV-2 variants in central India retrospectively (including the first known occurrence of SARS-CoV-2 in Madhya Pradesh).
View Article and Find Full Text PDFGenetic diversity and genomic epidemiology of SARS-CoV-2 during the first 3 years of the pandemic in Morocco: comprehensive sequence analysis, including the unique lineage B.1.528 in Morocco.
Access Microbiol
October 2024
Laboratory of Physiopathology and Molecular Genetics, Faculty of Sciences Ben M'Sik, Hassan II University of Casablanca (Morocco), Avenue Cdt Driss El Harti, PB 7955 Sidi Othman, Casablanca, Morocco.
During the 3 years following the emergence of the COVID-19 pandemic, the African continent, like other regions of the world, was substantially impacted by COVID-19. In Morocco, the COVID-19 pandemic has been marked by the emergence and spread of several SARS-CoV-2 variants, leading to a substantial increase in the incidence of infections and deaths. Nevertheless, the comprehensive understanding of the genetic diversity, evolution, and epidemiology of several viral lineages remained limited in Morocco.
View Article and Find Full Text PDFSARS-CoV-2 Delta and Omicron variants resist spike cleavage by human airway trypsin-like protease.
J Clin Invest
September 2024
Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Article Synopsis
- Soluble factors in the upper respiratory tract, specifically a protease called HAT, can help defend against SARS-CoV-2 by reducing its infectivity through cleavage of the virus's spike protein.
- In studies, infected mice showed increased levels of HAT, which effectively blocked the virus's ability to attach to and fuse with host cells.
- However, HAT was found to be less effective against the Delta and certain Omicron variants due to mutations near the cleavage site that rendered it resistant.
Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients.
J Med Virol
June 2024
Unit of Clinical Microbiology, Department of Health Sciences, "Magna Græcia" University Hospital, Catanzaro, Italy.
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) persistence in COVID-19 patients could play a key role in the emergence of variants of concern. The rapid intra-host evolution of SARS-CoV-2 may result in an increased transmissibility, immune and therapeutic escape which could be a direct consequence of COVID-19 epidemic currents. In this context, a longitudinal retrospective study on eight consecutive COVID-19 patients with persistent SARS-CoV-2 infection, from January 2022 to March 2023, was conducted.
View Article and Find Full Text PDFGenomic epidemiology of SARS-CoV-2 δ sublineages of the second wave of 2021 in Antioquia, Colombia.
Biomedica
March 2024
Laboratorio Departamental de Salud Pública de Antioquia, Secretaría Seccional de Salud y Protección Social de Antioquia, Medellín, Colombia.
Article Synopsis
- The study examines the genetic diversity and prevalence of various SARS-CoV-2 δ sublineages in Antioquia, highlighting the significant impact of the δ variant during the pandemic.
- Researchers analyzed 1,115 genomes from the GISAID database, identifying 24 sublineages with AY.25 being the most prevalent, showing a notable mutation frequency.
- The findings suggest that the AY.25 sublineage has a transmission advantage due to key mutations (L452R and P681R) that might enhance immune evasion and reduce drug efficacy against the virus.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!